Universität zu Köln

Journal Article

Baertsch, Marc-A., Schlenzka, Jana, Christina, Habermehl, Hielscher, Thomas, Raab, Marc S., Hillengass, Jens, Mueller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Brossart, Peter, Goerner, Martin, Klein, Stefan A., Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans-Walter, Scheid, Christoph, Nogai, Axel, Salwender, Hans Juergen, Noppeney, Richard, Weisel, Katja and Goldschmidt, Hartmut (2018). Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Baertsch, Marc-Andrea, Mai, Elias K., Hielscher, Thomas, Bertsch, Uta, Salwender, Hans J., Munder, Markus, Fuhrmann, Stephan ORCID: 0000-0002-7785-2565, Duehrsen, Ulrich, Brossart, Peter, Neben, Kai, Schlenzka, Jana, Kunz, Christina, Raab, Marc S., Hillengass, Jens, Jauch, Anna, Seckinger, Anja, Hose, Dirk, Luntz, Steffen, Sonneveld, Pieter, Lokhorst, Henk, Martin, Hans, Goerner, Martin, Hoffmann, Martin, Lindemann, Hans-Walter, Bernhard, Helga, Blau, Igor W., Scheid, Christof, Besemer, Britta, Weisel, Katja C., Haenel, Mathias, Duerig, Jan and Goldschmidt, Hartmut (2021). Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma. Blood Cancer J., 11 (1). LONDON: SPRINGERNATURE. ISSN 2044-5385

Baertsch, Marc-Andrea, Schlenzka, Jana, Lisenko, Katharina, Krzykalla, Julia, Becker, Natalia, Weisel, Katja, Noppeney, Richard, Martin, Hans, Lindemann, Hans W., Haenel, Mathias, Nogai, Axel, Scheid, Christof, Salwender, Hans ORCID: 0000-0001-7803-0814, Fenk, Roland, Graeven, Ullrich, Reimer, Peter, Schmidt-Hieber, Martin, Goerner, Martin, Schmidt-Wolf, Ingo G. H., Klein, Stefan, Ho, Anthony D., Goldschmidt, Hartmut and Wuchter, Patrick (2017). Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE. Eur. J. Haematol., 99 (1). S. 42 - 51. HOBOKEN: WILEY. ISSN 1600-0609

Baertsch, Marc-Andrea, Schlenzka, Jana, Mai, Elias K., Merz, Maximilian, Hillengass, Jens, Raab, Marc S., Hose, Dirk, Wuchter, Patrick, Ho, Anthony D. ORCID: 0000-0002-1656-0833, Jauch, Anna, Hielscher, Thomas, Kunz, Christina, Luntz, Steffen, Klein, Stefan, Schmidt-Wolf, Ingo G. H., Goerner, Martin, Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Salwender, Hans ORCID: 0000-0001-7803-0814, Scheid, Christof, Nogai, Axel, Haenel, Mathias, Lindemann, Hans W., Martin, Hans, Noppeney, Richard, Weisel, Katja and Goldschmidt, Hartmut (2016). Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma. BMC Cancer, 16. LONDON: BMC. ISSN 1471-2407

Bazarbachi, Abdul Hamid, Labopin, Myriam, Kroger, Nicolaus, Brecht, Arne, Blaise, Didier, Clausen, Johannes, Fanin, Renato, Einsele, Herman, Cavanna, Luigi, Itala-Remes, Maija, Bulabois, Claude Eric, Kundgen, Lukas, Martin, Hans, Schmid, Christof, Wagner-Drouet, Eva Maria, Alakel, Nael, Bazarbachi, Ali, Savani, Bipin, Nagler, Arnon and Mohty, Mohamad (2021). Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia. Clin. Lymphoma Myeloma Leuk., 21 (12). S. 831 - 841. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669

Bruch, Peter-Martin ORCID: 0000-0002-9992-3109, Dietrich, Sascha ORCID: 0000-0002-0648-1832, Finel, Herve, Boumendil, Ariane, Greinix, Hildegard ORCID: 0000-0002-2780-3300, Heinicke, Thomas ORCID: 0000-0002-4049-7854, Bethge, Wolfgang ORCID: 0000-0001-6052-2618, Beelen, Dietrich ORCID: 0000-0001-5050-220X, Schmid, Christoph ORCID: 0000-0001-7070-487X, Martin, Hans, Castagna, Luca, Scheid, Christof, Schaefer-Eckart, Kerstin, Bittenbring, Joerg, Finke, Juergen, Sengeloev, Henrik, Heiblig, Mael, Cornelissen, Jan, Chevallier, Patrice, Mohty, Mohamad, Robinson, Stephen, Montoto, Silvia and Dreger, Peter . Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters. Leukemia. LONDON: SPRINGERNATURE. ISSN 1476-5551

Christopeit, Maximilian ORCID: 0000-0003-4627-0412, Kuss, Oliver ORCID: 0000-0003-3301-5869, Finke, Juergen, Bacher, Ulrike, Beelen, Dietrich Wilhelm, Bornhaeuser, Martin, Schwerdtfeger, Rainer, Bethge, Wolfgang Andreas, Basara, Nadezda, Gramatzki, Martin, Tischer, Johanna, Kolb, Hans-Jochem, Uharek, Lutz, Meyer, Ralf G., Bunjes, Donald, Scheid, Christof, Martin, Hans, Niederwieser, Dietger, Kroeger, Nicolaus, Bertz, Hartmut, Schrezenmeier, Hubert and Schmid, Christoph (2013). Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change. J. Clin. Oncol., 31 (26). S. 3259 - 3276. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Goldschmidt, Hartmut, Baertsch, Marc-A., Schlenzka, Jana, Becker, Natalia, Christina, Habermehl, Hielscher, Thomas, Raab, Marc S., Hillengass, Jens, Mueller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Brossart, Peter, Goerner, Martin, Klein, Stefan A., Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans-Walter, Scheid, Christoph, Nogai, Axel, Salwender, Hans Juergen, Noppeney, Richard and Weisel, Katja (2018). Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goldschmidt, Hartmut, Baertsch, Marc-Andrea, Schlenzka, Jana, Becker, Natalia, Habermehl, Christina, Hielscher, Thomas, Raab, Marc-Steffen, Hillengass, Jens, Sauer, Sandra, Mueller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Hose, Dirk, Seckinger, Anja, Brossart, Peter, Goerner, Martin, Klein, Stefan, Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans W., Scheid, Christoph, Nogai, Axel, Salwender, Hans, Noppeney, Richard, Besemer, Britta and Weisel, Katja . Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE. Leukemia. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Hummel, Manuela, Hielscher, Thomas, Salwender, Hans Juergen, Scheid, Christof, Martin, Hans, Bertsch, Uta, Goldschmidt, Hartmut, Seckinger, Anja and Hose, Dirk (2018). Quantitative Integrative Prediction of Survival Probability in Multiple Myeloma Using Molecular and Clinical Prognostic Factors in 657 Patients Treated with Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Mai, Elias K., Hielscher, Thomas, Bertsch, Uta, Schlenzka, Jana, Salwender, Hans J., Munder, Markus, Gerecke, Christian, Duehrsen, Ulrich, Brossart, Peter, Neben, Kai, Hillengass, Jens, Raab, Marc S., Merz, Maximilian, Baertsch, Marc-Andrea, Jauch, Anna, Hose, Dirk, Martin, Hans, Lindemann, Hans-Walter, Blau, Igor W., Scheid, Christof, Weisel, Katja C. and Goldschmidt, Hartmut (2019). Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma. Leukemia, 33 (1). S. 258 - 262. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Mai, Elias Karl ORCID: 0000-0002-6226-1252, Kunz, Christina, Bertsch, Uta, Salwender, Hans-Juergen, Pfreundschuh, Michael, Duehrsen, Ulrich, Brossart, Peter, Peter, Norma, Neben, Kai, Hielscher, Thomas, Hillengass, Jens, Martin, Hans, Lindemann, Hans Walter, Scheid, Christof, Weisel, Katja C., Blau, Igor W. and Goldschmidt, Hartmut (2015). Impact of Severe Infections during Induction Therapy on Dosage, Response and Survival in Newly Diagnosed Multiple Myeloma - a Subgroup Analysis from the Randomized Phase III Trial GMMG-HD4. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Seckinger, Anja, Salwender, Hans Juergen, Martin, Hans, Scheid, Christof, Hielscher, Thomas, Bertsch, Uta, Hummel, Manuela, Jauch, Anna, Knauf, Wolfgang, Emde, Martina, Beck, Susanne, Neben, Kai, Lokhorst, Henk M., van der Holt, Bronno, Duehrsen, Ulrich, Duerig, Jan, Lindemann, Hans-Walter, Schmidt-Wolf, Ingo, Haenel, Mathias, Lathan, Bernd, Raab, Marc S., Mueller-Tidow, Carsten, Sonneveld, Pieter, Blau, Igor Wolfgang, Hillengass, Jens, Weisel, Katja, Goldschmidt, Hartmut and Hose, Dirk (2018). Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trail - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020